https://www.selleckchem.com/pr....oducts/vps34-in1.htm
OBJECTIVES Autologous CD133+ bone marrow stem cells may improve cardiac function. This randomized, single-blind clinical trial inquired whether a combined transepicardial and transseptal implantation of CD133+ stem cells during coronary artery bypass grafting (CABG) improve cardiac function with ejection fraction (EF) changes as a primary endpoint in patients with low EF. METHODS Thirty patients with coronary heart disease and EF less then 35% were randomized to undergo CABG alone or CABG with transseptal and transepicardial implantat
Like
Comment
Share
